Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Fibroblast Antibody (ER-TR7) - BSA Free, Novus Biologicals™

Rat Monoclonal Antibody has been used in 16 publications
Supplier: Novus Biologicals NB10064932
Description
Fibroblast Monoclonal specifically detects Fibroblast in Mouse samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Frozen.Specifications
Fibroblast | |
Monoclonal | |
1.0 mg/mL | |
Flow Cytometry 1:10-1:1000, Immunohistochemistry 1:300-1:500. Use reported in scientific literature (PMID 22042977), Immunocytochemistry/Immunofluorescence 1:10-1:500, Immunohistochemistry-Paraffin reported in scientific literature (PMID 35794106), Immunohistochemistry-Frozen 1:500 | |
Rat | |
Protein G purified | |
RUO | |
Primary | |
Mouse | |
Purified |
Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen) | |
ER-TR7 | |
Unconjugated | |
reticular fibroblast | |
Isolated C3H thymic stromal cells | |
0.125 mg | |
Fibroblast Cell Markers | |
NB100-64932 recognizes ER-TR7, an antigen that is located in the cytoplasm of reticular fibroblasts and is a component of the extracellular matrix of lymphoid and non-lymphoid organs. The antigen recognized by clone ER-TR7 has not been identified but studies suggest that it is likely to be distinct from laminin, fibronectin, collagen types I-IV, heparin sulphate proteoglycan, entactin and nidogen. Clone ER-TR7 has been used to stain the microanatomy of various organs and also stains subendothelial deposits in atherosclerotic plaques. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
IgG2a |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction